17:03 , Oct 26, 2018 |  BC Week In Review  |  Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

With $33 million in new series A funding, a portfolio of preclinical assets from The Medicines Co. (NASDAQ:MDCO) and a BARDA deal, Qpex Biopharma Inc. (San Diego, Calif.) hopes to begin clinical studies of multiple...
15:56 , Oct 26, 2018 |  BioCentury  |  Finance

Rempex remix

New Enterprise Associates led Qpex Biopharma Inc.’s $33 million A round in hope that the management team will repeat its performance at Rempex Pharmaceuticals Inc. and The Medicines Co. (NASDAQ:MDCO) with a preclinical anti-infectives portfolio....
12:02 , Oct 22, 2018 |  BC Extra  |  Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

With $33 million in new series A funding, a portfolio of preclinical assets from The Medicines Co. (NASDAQ:MDCO) and a BARDA deal, Qpex Biopharma Inc. (San Diego, Calif.) hopes to begin clinical studies of multiple...
01:21 , Apr 3, 2015 |  BC Extra  |  Financial News

Financial tracks

MPM Capital hired Anthony Rosenberg as managing director. Rosenberg was global head of M&A and licensing at Novartis AG (NYSE:NVS; SIX:NOVN). Frazier Healthcare named Richard Maroun as an operating executive on its growth buyout team....
02:03 , Feb 14, 2015 |  BC Extra  |  Company News

TPG regains Aptalis unit from Actavis

Private equity firm TPG will acquire Aptalis Pharmaceutical Technologies, a pharmaceutical outsourcing and R&D business within the Aptalis subsidiary of Actavis plc (NYSE:ACT), for an undisclosed amount. TPG said it intends to use the business...
08:00 , Dec 8, 2014 |  BC Week In Review  |  Company News

Cortendo management update

Cortendo AB , Gothenburg, Sweden   Business: Endocrine/Metabolic   Hired: Ruth Thieroff-Ekerdt as CMO, effective Dec. 15, formerly CMO of Aptalis Pharma Inc. , which Forest Laboratories Inc. acquired; Actavis plc subsequently acquired Forest  ...
07:00 , Apr 28, 2014 |  BC Week In Review  |  Company News

Lupin management update

Lupin Ltd. (NSE:LUPIN; BSE:500257), Mumbai, India   Business: Pharmaceuticals, Cardiovascular, Endocrine/Metabolic   Hired: Theresa Stevens as chief corporate development officer for global operations, formerly chief corporate development officer for M&A, strategy and global business development...
07:00 , Mar 17, 2014 |  BC Week In Review  |  Company News

Synergy management update

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), New York, N.Y.   Business: Gastrointestinal   Hired: Marino Garcia as SVP of corporate development, a newly created position, formerly VP of global business development at Aptalis Holdings Inc. , which...
08:00 , Feb 24, 2014 |  BC Week In Review  |  Company News

Actavis, Forest Laboratories deal

Generics company Actavis will acquire specialty pharma Forest Laboratories in a cash and stock deal that the companies said values Forest at about $89.48 per Forest share, or about $25 billion. The price is a...
08:00 , Feb 24, 2014 |  BioCentury  |  Finance

Tree hugging

Forest Laboratories Inc. 's efforts to renew its growth by in-licensing commercial stage products and cutting costs culminated in last week's $25 billion takeout offer from Actavis plc . Recent Forest investors are getting about...